In a move that has sent shockwaves through the biotechnology sector, the U.S. Food and Drug…
Tag: Pharmaceuticals
Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth
Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth #Ironwood #Pharmaceuticals #Setting #Strong #Foundation…
Telix Pharmaceuticals: Riding the Wave of Innovation in Radiopharmaceuticals
As I write this, Telix Pharmaceuticals (TLX) is making headlines with a whopping 6.69% gain on…
Syndax Pharmaceuticals: Down But Not Out
Syndax Pharmaceuticals: Down But Not Out #Syndax #Pharmaceuticals
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients…
Vertex Pharmaceuticals: A Look At Their Pain Therapy Program
Vertex Pharmaceuticals: A Look At Their Pain Therapy Program #Vertex #Pharmaceuticals #Pain #Therapy #Program
Telix Pharmaceuticals: Building A Radiopharma Powerhouse
Telix Pharmaceuticals: Building A Radiopharma Powerhouse #Telix #Pharmaceuticals #Building #Radiopharma #Powerhouse
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability #Rigel #Pharmaceuticals #3Drug #Company #Reaches #Profitability
Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data
Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data #Xenon #Pharmaceuticals #Attractive #Epilepsy #Data
Centessa Pharmaceuticals: Smooth Move To New Programs, But Questions Remain
Centessa Pharmaceuticals: Smooth Move To New Programs, But Questions Remain #Centessa #Pharmaceuticals #Smooth #Move #Programs #Questions…
Amylyx Pharmaceuticals chief legal officer sells $31,954 in stock
Amylyx Pharmaceuticals chief legal officer sells $31,954 in stock#Amylyx #Pharmaceuticals #chief #legal #officer #sells #stock
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2024 Earnings Conference Call March 27, 2025 8:00 AM ET Company…
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2024 Earnings Call Transcript
Corvus Pharmaceuticals, Inc. (CRVS) Q4 2024 Earnings Call Transcript #Corvus #Pharmaceuticals #CRVS #Earnings #Call #Transcript
Arrowhead Pharmaceuticals Is Finally Arriving
Arrowhead Pharmaceuticals Is Finally Arriving #Arrowhead #Pharmaceuticals #Finally #Arriving
Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster
Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster #Alnylam #Pharmaceuticals #Ready #Blockbuster
Rhythm Pharmaceuticals regains rights to obesity drug in China
Rhythm Pharmaceuticals regains rights to obesity drug in China#Rhythm #Pharmaceuticals #regains #rights #obesity #drug #China
NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2024 Earnings Conference Call March 17, 2025 8:30 AM ET Company…
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on…
Verrica Pharmaceuticals, Inc. (VRCA) Q4 2024 Earnings Conference Call Transcript
Verrica Pharmaceuticals, Inc. (VRCA) Q4 2024 Earnings Conference Call Transcript #Verrica #Pharmaceuticals #VRCA #Earnings #Conference #Call…
REGN IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in S
REGN IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in…
Apellis Pharmaceuticals: A Mixed Bag
Apellis Pharmaceuticals: A Mixed Bag #Apellis #Pharmaceuticals #Mixed #Bag
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2024 Earnings Call Transcript
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company…